SpyGlass Pharma, Inc. Common Stock

NASDAQ:SGP

Biotechnology

Healthcare
$29.68 +2.49%

+$0.45 today

Market cap
$993.14M
Beta
-0.34
P/E (TTM)
-14.1
EPS (TTM)
-$1.32
52W Low $17.06High $32.44

Volume 0.10M

Average 0.09M

SGP Other Non-current Liabilities

Long-term obligations not reported separately, such as lease or pension liabilities.

SpyGlass Pharma, Inc. Common StockNASDAQ: SGP

Other Non-current Liabilities · Q1 FY2026 · quarter ended Mar 2026

Other non-current liabilities of $0 in Q1 FY2026

Q1 FY2026 other non-current liabilities was $0.

Context

  • Other non-current liabilities amounted to 0.0% of total assets at the end of Q1 FY2026.

Sources:Balance SheetText generated from reported figures; not investment advice.

Latest quarterMar 2026
$0-100.0% QoQ
Last fiscal yearDec 2025
$204.54M— YoY
Other Non-current Liabilities past and forecast growth by horizon
Horizon Past Forecast Difference
Quarter———
1 year———
3-year CAGR———
5-year CAGR——
10-year CAGR——

Other Non-current Liabilities history

USD · from the balance sheet

Latest · FY2025
204.54M USD
Year-over-year change
—

Other Non-current Liabilities vs competitors

How SGP compares with its peers on the latest reported figures

  • Peers report in different currencies, so other non-current liabilities is compared through growth and share of total assets rather than absolute size.
  • Other non-current liabilities amounts to 0.0% of total assets for SGP, versus a peer median of 1.4%.
SGP Competitors
Other Non-current Liabilities for SGP and competitors
Company Period Latest balance YoY 3-year CAGR% of assets
ALCAlcon Inc.Sep 2026$808M USD-14.3%+33.7%2.6%
BLCOBausch + Lomb CorporationJun 2026$435M USD-19.3%+4.6%3.1%
GKOSGlaukos CorporationJun 2026$32.43M USD+5.4%—3.5%
OCULOcular Therapeutix, Inc.Mar 2026$12.98M USD-7.3%+22.9%1.8%
STAASTAAR Surgical CompanyApr 2026$6.48M USD+9.5%+43.9%1.4%
OCSOculis Holding AGMar 2026CHF 1.65M CHF+27.1%+144.9%0.7%
EYPTEyePoint Pharmaceuticals, Inc.Mar 2026$55K USD-68.9%-47.5%0.0%
SGHTSight Sciences, Inc.Mar 2026$30K USD+57.9%-70.7%0.0%
SGPSpyGlass Pharma, Inc. Common StockMar 2026$0 USD——0.0%
RXSTRxSight, Inc.Mar 2026$0 USD——0.0%
Peer median (excluding SGP) —-0.9%+22.9%1.4%

Competitors are the stored peer set for SGP. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

SpyGlass Pharma, Inc. Common Stock

NASDAQ:SGP

Intrinsic Alpha fair value

Locked

Current Price

$29.68

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.